New research finds that the diabetes drug metformin changes stem cancer cells in a way that makes them easier to target with a new form of treatment. The findings could help treat triple-negative breast cancer, which is particularly aggressive. New research suggests that the drug metformin may be the key to tackling triple-negative breast cancer.